DESTINY PHARMA

destiny-pharma-logo

Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products. Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling the drug-resistant bacteria that are at the centre of a global healthcare crisis.

#People #Financial #Website #More

DESTINY PHARMA

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1996-01-01

Address:
Brighton, East Sussex, United Kingdom

Country:
United Kingdom

Website Url:
http://www.destinypharma.com

Total Employee:
11+

Status:
Active

Contact:
+441273704499

Email Addresses:
[email protected]

Total Funding:
46.55 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Apache Global Site Tag


Current Employees Featured

shaun-claydon_image

Shaun Claydon
Shaun Claydon Chief Financial Officer and Company Secretary @ Destiny Pharma
Chief Financial Officer and Company Secretary

stephanie-bewick_image

Stephanie Bewick
Stephanie Bewick Chief Business Officer @ Destiny Pharma
Chief Business Officer
2021-01-01

william-love_image

William Love
William Love Founder and Chief Scientific Officer @ Destiny Pharma
Founder and Chief Scientific Officer

neil-clark_image

Neil Clark
Neil Clark Chief Executive Officer @ Destiny Pharma
Chief Executive Officer
2017-01-01

Founder


william-love_image

William Love

Stock Details


Company's stock symbol is LSE:DEST

Investors List

the-cystic-fibrosis-foundation_image

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation investment in Grant - Destiny Pharma

antimicrobial-resistance_image

Antimicrobial resistance

Antimicrobial resistance investment in Grant - Destiny Pharma

cms-medical-venture-investment_image

CMS Medical Venture Investment

CMS Medical Venture Investment investment in Post-IPO Equity - Destiny Pharma

downing_image

Downing LLP

Downing LLP investment in Post-IPO Equity - Destiny Pharma

china-medical-system-holdings-limited_image

China Medical System Holdings Limited

China Medical System Holdings Limited investment in Venture Round - Destiny Pharma

downing-ventures_image

Downing Ventures

Downing Ventures investment in Venture Round - Destiny Pharma

juno-capital_image

Juno Capital Partners

Juno Capital Partners investment in Venture Round - Destiny Pharma

angel-cofund_image

ACF Investors

ACF Investors investment in Venture Round - Destiny Pharma

longbow-capital_image

Longbow Capital

Longbow Capital investment in Venture Round - Destiny Pharma

Official Site Inspections

http://www.destinypharma.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.95 K

  • Host name: cloudhost-69408.uk-south-2.nxcli.net
  • IP address: 165.84.219.41
  • Location: Byfleet United Kingdom
  • Latitude: 51.3388
  • Longitude: -0.474
  • Timezone: Europe/London
  • Postal: KT14

Loading ...

More informations about "Destiny Pharma"

Destiny Pharma | Home - Destiny Pharma

Jan 8, 2024 NTCD-M3 NTCD-M3, our lead biotherapeutic asset, targets CDI. The company owns global rights to the worldโ€™s most advanced single strain, live biotherapeutic product ...See details»

About us - Destiny Pharma

About us. Destiny Pharma is a clinical phase biotechnology company dedicated to infection prevention. The company has two late stage clinical programmes and an earlier preclinical โ€ฆSee details»

Destiny Pharma - Crunchbase Company Profile

Contact Email [email protected] Phone Number +441273704499 Destiny Pharma is an innovative pharmaceutical company dedicated to the โ€ฆSee details»

Destiny Pharma Limited | LinkedIn

Destiny Pharma Limited | 2,093 followers on LinkedIn. Infection prevention biotech with late-stage assets targeting C. difficile and post-surgical S. aureus infections | Destiny Pharma is a ...See details»

Destiny Pharma Company Profile | Management and Employees โ€ฆ

[email protected]: Destiny Pharma Top Competitors. Company Employees Revenue Top technologies; Patrys Ltd. n/a: $18 K: Vidac Pharma Ltd. n/a: $1.5 M: Trevena Inc. n/a: โ€ฆSee details»

Company Destiny Pharma plc London S.E. - MarketScreener.com

Aug 31, 2011 Destiny Pharma plc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | London S.E.: DEST | โ€ฆSee details»

Destiny Pharma | VentureRadar

Website: http://www.destinypharma.com. Develops novel antimicrobial drugs using XF platform and biotherapeutic products, targeting antibiotic-resistant bacteria, with ...See details»

Destiny Pharma - Products, Competitors, Financials, Employees ...

About Destiny Pharma. Destiny Pharma is a clinical stage biotechnology company that develops medicines for infection prevention. The company works on microbiome-based biotherapeutics โ€ฆSee details»

Destiny Pharma - Craft

Destiny Pharma has 5 employees at their 1 location and $4.7 m in total funding,. See insights on Destiny Pharma including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

Investors - Destiny Pharma

Destiny Pharma Limited - In Administration; Sussex Innovation Centre; Science Park Square; Brighton; BN1 9SB UKSee details»

Destiny Pharma Plc Company Profile - Overview - GlobalData

Website www.destinypharma.com Telephone 44 1273 704440. No of Employees 19. Industry Pharmaceuticals and Healthcare. Gain access to our premium ...See details»

Destiny Pharma - Company Profile - Tracxn

Oct 21, 2024 Destiny Pharma ranks 10th among 200 active competitors. 76 of its competitors are funded while 37 have exited. Overall, Destiny Pharma and its competitors have raised over โ€ฆSee details»

Destiny Pharma - VentureRadar

"Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention.See details»

Destiny Pharma - Overview, News & Similar companies - ZoomInfo

Jan 15, 2021 Popular Searches Destiny Pharma PLC Destiny Pharma Destiny Pharma Ltd Destiny Ltd Destinypharma SIC Code 28,283 NAICS Code 32,325 Show more. Similar โ€ฆSee details»

Destiny Pharma plc Company Overview, Contact Details

Mar 16, 2023 Lead Drug Candidate Partnership Destiny Pharma partnered with Sebela Pharmaceuticals for its NTCD-M3 program in a deal potentially worth up to $570 million plus โ€ฆSee details»

Leadership - Destiny Pharma

Destiny Pharma Limited - In Administration; Sussex Innovation Centre; Science Park Square; Brighton; BN1 9SB UKSee details»

Reports And Presentations - Destiny Pharma

Jul 15, 2024 Presentations. 2023 Full Year results presentation (25 April 2024) XF Platform event (17 October 2023) 2023 Interim results presentation (20 September 2023)See details»

Destiny Pharma | XF-73 Dermal infection project advances into ...

Nov 15, 2022 [email protected] +44 (0)1273 704 440. Optimum Strategic Communications Nick Bastin, Manel Mateus, Eleanor Cooper โ€ฆSee details»

Latest News - Destiny Pharma

Destiny Pharma Limited - In Administration; Sussex Innovation Centre; Science Park Square; Brighton; BN1 9SB UKSee details»

linkstock.net © 2022. All rights reserved